Earnings History Data for Vertex Pharmaceuticals Incorporated (VRTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2024	AH		VRTX	Vertex Pharmaceuticals Incorporated	122,850	4.04	3.61	3.67	Vertex Pharmaceuticals Non-GAAP EPS of $4.38 beats by $0.25, revenue of $2.77B beats by $80M [11/4/2024 4:03 PM]	499.10	26.30 (5.56%)	482.53	9.73 (2.06%)	341.90 - 510.64	1,345,024	1,000,000	4,600
Vertex Pharmaceuticals Non-GAAP EPS of $4.38 beats by $0.25, revenue of $2.77B beats by $80M [11/4/2024 4:03 PM] Vertex raises 2024 product revenue outlook following Q3 beats [11/4/2024 4:48 PM] Earnings Snapshot: Vertex Pharmaceuticals top Q3 estimates, raises FY revenue guidance [11/4/2024 5:35 PM] Vertex Reports Third Quarter 2024 Financial Results [2024-11-04 04:01PM]
01-08-2024	AH		VRTX	Vertex Pharmaceuticals Incorporated	129,700	-13.27	-12.28	3.53	Vertex Pharmaceuticals Non-GAAP EPS of -$12.83 misses by $1.08, revenue of $2.65B misses by $10M [8/1/2024 4:02 PM]	495.09	-10.69 (-2.11%)	502.01	-3.77 (-0.75%)	340.20 - 510.64	1,155,392	1,120,000	9,948
Vertex Pharmaceuticals Non-GAAP EPS of -$12.83 misses by $1.08, revenue of $2.65B misses by $10M [8/1/2024 4:02 PM] Vertex boosts revenue forecast on back of cystic fibrosis franchise growth [8/2/2024 11:24 AM]
06-05-2024	AH		VRTX	Vertex Pharmaceuticals Incorporated	103,360	4.29	3.66	2.67	Vertex Pharmaceuticals Non-GAAP EPS of $4.76 beats by $0.70, revenue of $2.69B beats by $110M [5/6/2024 4:04 PM]	409.95	7.45 (1.85%)	410.25	7.75 (1.93%)	320.01 - 448.40	1,361,988	1,050,000	24,542
Vertex Pharmaceuticals Non-GAAP EPS of $4.76 beats by $0.70, revenue of $2.69B beats by $110M [5/6/2024 4:04 PM] Vertex provides another EPS beat as net income rises 56% in Q1 [5/6/2024 5:21 PM]
05-02-2024	AH		VRTX	Vertex Pharmaceuticals Incorporated	111,800	3.57	3.85	3.33	Vertex Pharmaceuticals Non-GAAP EPS of $4.20 beats by $0.11, revenue of $2.52B beats by $10M [2/5/2024 4:09 PM]	416.01	-12.88 (-3.00%)	429.89	1.00 (0.23%)	283.60 - 448.40	3,962,136	1,730,000	19,172
Vertex Pharmaceuticals Non-GAAP EPS of $4.20 beats by $0.11, revenue of $2.52B beats by $10M [2/5/2024 4:09 PM] Vertex to seek FDA, EMA approval for CF therapy by mid-2024 [2/5/2024 4:42 PM] Evercore downgrades Vertex; cites price, pain franchise headwinds [2/6/2024 12:06 PM]
06-11-2023	AH		VRTX	Vertex Pharmaceuticals Incorporated	97,190	3.67	3.53	3.62	Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M [11/6/2023 4:02 PM]	378.54	-7.22 (-1.87%)	377.40	-8.36 (-2.17%)	282.21 - 387.42	1,514,315	1,130,000	3,667
Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M [11/6/2023 4:02 PM] Vertex shares dip 2% as Q3 revenue, guidance falls shy of Street estimates [11/6/2023 6:57 PM] Vertex Pharmaceuticals ends development of Phase 2 drug for AATD [11/7/2023 11:19 AM]
01-08-2023	AH		VRTX	Vertex Pharmaceuticals Incorporated	91,190	3.53	3.47	3.25	Vertex Pharmaceuticals Non-GAAP EPS of $3.89 beats by $0.01, revenue of $2.49B beats by $70M [8/1/2023 4:02 PM]	358.52	10.78 (3.10%)	348.00	0.26 (0.07%)	271.61 - 367.00	1,769,099	1,430,000	1,984
Vertex Pharmaceuticals Non-GAAP EPS of $3.89 beats by $0.01, revenue of $2.49B beats by $70M [8/1/2023 4:02 PM]
01-05-2023	AH	4:00 PM ET (May 1)	VRTX	Vertex Pharmaceuticals	87,249	2.67	2.95	0.00	Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M [5/1/2023 4:02 PM]	346.23	1.23 (0.36%)	341.87	-3.13 (-0.91%)	233.01 - 354.46	1,657,360	1,200,000	1,229
Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M [5/1/2023 4:02 PM] Vertex Q1 beats thanks to strong Trikafta year-over-year sales increase [5/1/2023 5:23 PM]
07-02-2023	AH	4:00 PM ET (Feb 7)	VRTX	Vertex Pharmaceuticals Incorporated	77,980	3.33	3.11	3.18	Vertex Pharmaceuticals Non-GAAP EPS of $3.76 beats by $0.25, revenue of $2.3B in-line [2/7/2023 4:03 PM]	293.38	-15.16 (-4.91%)	303.00	-5.54 (-1.80%)	225.28 - 325.19	1,718,442	1,490,000	3,077
Vertex under fire as activists demand generics for best-selling drug [2/7/2023 1:35 PM] Vertex Pharmaceuticals Non-GAAP EPS of $3.76 beats by $0.25, revenue of $2.3B in-line [2/7/2023 4:03 PM] Vertex indicates slowdown in growth; announces share buybacks [2/7/2023 4:36 PM]
27-10-2022	AH	4:00 PM ET (Oct 27)	VRTX	Vertex Pharmaceuticals Incorporated	79,300	3.62	3.31	3.25	Vertex Pharmaceuticals Non-GAAP EPS of $4.01 beats by $0.37, revenue of $2.33B beats by $100M [10/27/2022 4:07 PM]	313.75	25.87 (8.98%)	303.00	15.11 (5.25%)	179.96 - 316.48	2,751,593	1,560,000	10,723
Vertex Pharmaceuticals Non-GAAP EPS of $4.01 beats by $0.37, revenue of $2.33B beats by $100M [10/27/2022 4:07 PM] Vertex Q3 net income rises 14% as it raises full-year revenue guidance [10/27/2022 5:16 PM] Vertex Reports Third Quarter 2022 Financial Results [Oct-27-22 04:01PM] Better Buy: CRISPR Therapeutics vs. Bluebird Bio [Oct-27-22 09:30AM] Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 81% Above Its Share Price [Oct-27-22 09:01AM] Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More [Oct-26-22 02:48PM] 2 Monster Stocks to Buy Without Any Hesitation [Oct-26-22 05:30AM] Dow Jones Futures: Apple Holds, Amazon Joins Megacap Meltdown; What To Do Now [Oct-28-22 01:00AM] Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call Transcript [Oct-27-22 10:00PM] Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Surpass Estimates [Oct-27-22 05:25PM] Vertex Shrugs Off Regular-Session Malaise As International Sales Drive Quarterly Beat [Oct-27-22 04:55PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	VRTX	Vertex Pharmaceuticals Incorporated	71,690	3.25	3.06	2.80	Vertex Pharmaceuticals Non-GAAP EPS of $3.60 beats by $0.10, revenue of $2.2B beats by $70M [8/4/2022 4:05 PM]	288.03	13.18 (4.80%)	288.03	0.0 (0.00%)	176.36 - 296.84	2,361,510	1,400,000	16,915
Vertex Pharmaceuticals Non-GAAP EPS of $3.60 beats by $0.10, revenue of $2.2B beats by $70M [8/4/2022 4:05 PM] Vertex raises 2022 revenue guidance on back of Q2 top and bottom line beats [8/4/2022 4:48 PM] Vertex Reports Second Quarter 2022 Financial Results [Aug-04-22 04:01PM] 12 Best Healthcare Stocks To Buy Now [Aug-04-22 03:01PM] Dow Jones Falls After Jobless Data; Alibaba Jumps On Earnings [Aug-04-22 09:59AM] Dow Jones Rallies Amid Key Economic Data; AMD Tumbles On Weak Sales Outlook [Aug-03-22 09:50AM] Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More [Aug-03-22 09:48AM] Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks [Aug-03-22 08:46AM]
05-05-2022	AH	4:00 PM ET (May 5)	VRTX	Vertex Pharmaceuticals Incorporated	66,940	3.16	3.17	2.54	Vertex Pharmaceuticals Non-GAAP EPS of $3.52 misses by $0.02, revenue of $2.1B beats by $30M [5/5/2022 4:05 PM]	253.93	-12.44 (-4.67%)	253.93	0.0 (0.00%)	176.36 - 292.75	2,136,392	1,870,000	33,328
Vertex Pharmaceuticals Non-GAAP EPS of $3.52 misses by $0.02, revenue of $2.1B beats by $30M [5/5/2022 4:05 PM] Vertex Pharmaceuticals Q1 net income rises 17% on strong increase in Trikafta sales [5/5/2022 5:52 PM] Vertex cut to neutral at Baird as stock fairly valued and no further upside [5/6/2022 9:02 AM] Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More [May-04-22 03:19PM] Clovis (CLVS) Q1 Loss Wider than Expected, Revenues Miss [May-04-22 02:21PM] Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News [May-04-22 01:39PM] Blueprint Medicines (BPMC) Q1 Loss in Line, Revenues Top Mark [May-04-22 01:22PM] Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies [May-04-22 11:39AM] TEVA Matches Q1 Earnings Estimates, Lowers 2022 Sales View [May-04-22 11:07AM] Should You Buy Vertex (VRTX) Ahead of Earnings? [May-04-22 08:42AM] 5 Large-Cap Stocks to Buy Ahead of Q1 Earnings This Week [May-04-22 07:02AM] How Bad Is This News for Vertex Pharmaceuticals? [May-04-22 06:00AM] This Stock Is Trouncing the Market in 2022 -- and Its Prospects Just Got Even Better [May-05-22 05:52AM] Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 137% [May-05-22 11:14AM] Vertex Reports First Quarter 2022 Financial Results [May-05-22 04:01PM] Vertex Narrowly Beats Quarterly Sales Forecasts, But Profit Misses By A Nickel [May-05-22 04:17PM] Dow Jones Futures: Stocks Plunge As Treasury Yields Soar In Delayed Fed Reaction [May-05-22 05:04PM] Why Vertex Pharma's Pipeline Has Never Been More Important [May-05-22 05:06PM] Vertex Pharmaceuticals (VRTX) Q1 Earnings Miss Estimates [May-05-22 05:15PM] Vertex Pharmaceuticals (VRTX) Q1 2022 Earnings Call Transcript [May-06-22 02:03AM] Dow Jones Futures Fall After Stocks Plunge, Treasury Yields Soar In Delayed Fed Reaction [May-06-22 07:14AM] Stocks That Lift This JPMorgan Fund In Down Market [May-06-22 07:00AM] Indexes Open Lower, Continue Sell-Off; These Industry Groups Are Moving On Earnings [May-06-22 10:24AM] Apellis (APLS) Hit By Wider-Than-Expected Q1 Loss, Revenues Top [May-06-22 09:55AM] Is Lantheus (LNTH) Outperforming Other Medical Stocks This Year? [May-06-22 09:40AM] Deciphera (DCPH) Down Despite Narrower-Than-Expected Q1 Loss [May-06-22 11:02AM] STERIS (STE) to Report Q4 Earnings: What's in the Cards? [May-06-22 10:56AM] Vertex (VRTX) Q1 Earnings Lag, Sales Top, Expense View Tweaked [May-06-22 10:37AM] Ultragenyx's (RARE) Q1 Earnings & Revenues Miss Estimates [May-06-22 11:37AM] Stock Market Extends Losses On Jobs Reports, Rising Yields; Oil Stocks Lead Upside [May-06-22 02:03PM] Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results [May-06-22 01:23PM] Radius (RDUS) Q1 Loss Wider Than Expected, Revenues Decline [May-06-22 12:43PM] Stock Market Extends Losses On Jobs Reports, Rising Yields; Materials, Real Estate Add To Woes [May-06-22 03:20PM]
26-01-2022	AH	4:00 PM ET (Jan 26)	VRTX	Vertex Pharmaceuticals Incorporated	58,400	3.18	2.91	2.22	Vertex Pharmaceuticals Non-GAAP EPS of $3.37 beats by $0.08, revenue of $2.07B beats by $60M [1/26/2022 4:02 PM]	228.03	1.45 (0.64%)	230.00	3.42 (1.51%)	176.36 - 234.96	1,869,761	1,980,000	5,334
Vertex Pharmaceuticals Non-GAAP EPS of $3.37 beats by $0.08, revenue of $2.07B beats by $60M [1/26/2022 4:02 PM] Vertex Q4 2021 beats on top and bottom lines as non-GAAP income soars 31% [1/26/2022 5:13 PM] SWS Partners Buys Abbott Laboratories, Cognizant Technology Solutions Corp, American Homes 4 ... [Jan-25-22 01:38PM] 5 Buy-Ranked Stocks Likely to Beat on Earnings This Week [Jan-25-22 11:40AM] 2 No-Brainer Healthcare Stocks to Buy Right Now [Jan-25-22 10:15AM] 3 Green Flags for CRISPR Therapeutics' Future [Jan-26-22 07:56AM] The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals Inc., Marten Transport, Nucor, Seagate Technology and Sanderson Farms [Jan-26-22 08:33AM] Vertex Reports Fourth Quarter 2021 and Full Year Financial Results [Jan-26-22 04:01PM] Vertex Pharma Guides Up After Fourth-Quarter Earnings Easily Beat [Jan-26-22 04:15PM] Dow Jones Futures: Hawkish Fed Chief Powell Wipes Out Market Rally; Tesla Headlines Earnings Wave [Jan-26-22 05:26PM] Why Vertex Pharmaceuticals' Strong Outlook Wasn't Enough To Spark Shares [Jan-26-22 05:45PM] Dow Jones Futures: Hawkish Fed Chief Powell Wipes Out Market Rally; Tesla Leads Earnings Movers [Jan-26-22 06:06PM] Vertex Pharmaceuticals (VRTX) Surpasses Q4 Earnings and Revenue Estimates [Jan-26-22 05:15PM] Dow Jones Futures Fall After Fed Chief Powell Wipes Out Market Gains; Tesla Leads Earnings Movers [Jan-26-22 08:22PM] Dow Jones Futures Volatile After Fed Chief Powell Wipes Out Market Gains; Tesla Leads Earnings Movers [Jan-27-22 06:18AM] Dow Jones Futures Rise Amid Stock Market Volatility; Tesla Falls On Earnings, Apple Earnings Due [Jan-27-22 08:28AM] Dow Jones Futures Rise Amid Stock Market Volatility; Tesla Reverses On Earnings, Apple Earnings Due [Jan-27-22 08:51AM] Dow Jones Surges Amid Stock Market Volatility; Tesla Skids On Earnings, Apple Earnings Due [Jan-27-22 09:55AM] Vertex Pharma Nears Year-High As Bullish Outlook, Pipeline Promise Spark Shares [Jan-27-22 11:41AM] Biotech Stock Roundup: VRTX Q4 Earnings, GILD, INCYs Regulatory Updates & More [Jan-27-22 10:27AM] Vertex (VRTX) Q4 Earnings & Sales Beat, '22 View Upbeat [Jan-27-22 10:26AM] Looking for a Growth Stock? 3 Reasons Why Vertex (VRTX) is a Solid Choice [Jan-27-22 12:45PM]
02-11-2021	AH	4:00 PM ET (Nov 2)	VRTX	Vertex Pharmaceuticals Incorporated	47,220	3.25	2.74	2.36	Vertex Pharmaceuticals EPS beats by $0.51, beats on revenue [11/2/2021 4:05 PM]	188.53	7.13 (3.93%)	187.11	5.71 (3.15%)	176.36 - 242.99	3,415,800	1,480,000	17,437
Vertex Pharmaceuticals EPS beats by $0.51, beats on revenue [11/2/2021 4:05 PM] Vertex Pharma sets guidance ahead of consensus as revenue growth picks up [11/2/2021 4:29 PM] Was The Smart Money Right About Vertex Pharmaceuticals (VRTX)? [Nov-01-21 12:09PM] Cassava Sciences (SAVA) to Post Q3 Earnings: What's in Store? [Nov-01-21 11:32AM] CVS Health (CVS) to Report Q3 Earnings: What's in the Cards? [Nov-01-21 09:41AM] 3 No-Brainer Stocks to Invest $300 In Right Now [Nov-01-21 05:51AM] Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster? [Nov-02-21 06:52AM] Vertex Reports Third-Quarter 2021 Financial Results [Nov-02-21 04:01PM] Vertex Stock Pops On Quarterly Beat Driven By Its Triple-Pill For Cystic Fibrosis [Nov-02-21 04:12PM] Vertex Stock Pops As This One Key Driver Leads To A Beat-And-Raise [Nov-02-21 04:56PM] Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates [Nov-02-21 05:15PM] Vertex Pharmaceuticals Incorporated (VRTX) Q3 2021 Earnings Call Transcript [Nov-03-21 12:00AM] Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises '21 View [Nov-03-21 10:48AM]
29-07-2021	AH	4:00 PM ET (Jul 29)	VRTX	Vertex Pharmaceuticals Incorporated	52,510	2.80	2.25	2.26	Vertex Pharmaceuticals EPS beats by $0.75, beats on revenue [7/29/2021 4:09 PM]	201.64	1.26 (0.63%)	202.99	2.61 (1.30%)	185.32 - 283.45	1,731,038	2,250,000	13,681
Vertex Pharmaceuticals EPS beats by $0.75, beats on revenue [7/29/2021 4:09 PM] Vertex posts Q2 earnings beat, raises FY product revenue forecast [7/29/2021 4:41 PM] Vertex to Initiate Phase 3 Development Program for New Once-Daily Triple Combination Regimen in People With Cystic Fibrosis [Jul-28-21 08:00AM] 5 Stocks I Own That I Want to Add to When the Stock Market Crashes [Jul-28-21 05:51AM] Vertex Reports Second-Quarter 2021 Financial Results [Jul-29-21 04:01PM] Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Surpass Estimates [Jul-29-21 05:25PM] Vertex Pharmaceuticals Incorporated (VRTX) Q2 2021 Earnings Call Transcript [Jul-30-21 10:02AM] CRISPR Therapeutics (CRSP) Q2 Earnings Beat, Revenues Up Y/Y [Jul-30-21 10:31AM] 15 Most Valuable Biotech Companies in the World [Jul-30-21 12:31PM] Vertex (VRTX) Q2 Earnings Beat Estimates, 2021 Guidance Up [Jul-30-21 11:16AM]
29-04-2021	AH	4:00 PM ET (Apr 29)	VRTX	Vertex Pharmaceuticals Incorporated	56,160	2.54	2.38	2.21	Vertex Pharmaceuticals EPS beats by $0.29, beats on revenue [4/29/2021 4:05 PM]	217.97	6.11 (2.88%)	213.50	1.64 (0.77%)	202.56 - 306.08	2,124,484	1,460,000	9,276
Vertex Pharmaceuticals EPS beats by $0.29, beats on revenue [4/29/2021 4:05 PM] Vertex beats Q1 consensus as cystic fibrosis therapy drives revenue growth [4/29/2021 5:00 PM] Biotech Stock Roundup: BIIB, AMGN's Q1 Earnings Updates & Other Pipeline News [Apr-28-21 12:18PM] CRISPR Therapeutics (CRSP) Q1 Earnings Miss, Revenues Rise Y/Y [Apr-28-21 09:56AM] Vertex Announces European Commission Approval for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Cystic Fibrosis Patients 12 Years and Older With At Least One F508del Mutation in the CFTR gene [Apr-28-21 07:30AM] Vertex Reports First-Quarter 2021 Financial Results [Apr-29-21 04:01PM] Vertex Tops First-Quarter Expectations, Reiterates Strong Sales Outlook [Apr-29-21 04:13PM] Vertex Stock Muted After Beating Quarterly Views; What Could Spark Shares? [Apr-29-21 05:00PM] Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Surpass Estimates [Apr-29-21 05:25PM] Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript [Apr-29-21 10:01PM] Here's How Vertex Pharmaceuticals Beat Expectations in Q1 [Apr-30-21 06:05AM] 3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners [Apr-30-21 06:01AM] Have $1,000 to Invest? Buy These 2 Growth Stocks Right Now [Apr-30-21 06:50AM] Vertex (VRTX) Q1 Earnings Beat Estimates, Revenues Up Y/Y [Apr-30-21 08:12AM]
01-02-2021	AH	4:00 PM ET (Feb 1)	VRTX	Vertex Pharmaceuticals Incorporated	59,820	2.22	2.33	1.44	Vertex Pharmaceuticals EPS misses by $0.06, beats on revenue [2/1/2021 4:03 PM]	217.21	-14.56 (-6.28%)	227.25	-4.52 (-1.95%)	197.47 - 306.08	5,801,636	1,809,149	19,564
Vertex Pharmaceuticals EPS misses by $0.06, beats on revenue [2/1/2021 4:03 PM] Amicus shares rise on acquisition speculation from Vertex [2/2/2021 11:10 AM] Vertex (VRTX) Q4 Earnings Miss, Revenues Beat Estimates [Feb-02-21 10:25AM] Why Vertex Pharmaceuticals' Solid Q4 Results Weren't Good Enough [Feb-02-21 06:03AM] Vertex Pharmaceuticals Inc (VRTX) Q4 2020 Earnings Call Transcript [Feb-01-21 10:30PM] Markets Snap Back into Bullish Territory [Feb-01-21 05:56PM] Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results [Feb-01-21 04:01PM] Vertex Pharmaceuticals, Inc. to Host Earnings Call [Feb-01-21 02:30PM] 3 Top Stocks That'll Make You Richer in February (and Beyond) [Feb-01-21 06:06AM] Zacks.com featured highlights include: Crocs, AGCO, Meritage Homes and Vertex Pharmaceuticals [Feb-01-21 05:43AM]
29-10-2020	AH	4:00 PM ET (Oct 29)	VRTX	Vertex Pharmaceuticals Incorporated	55,270	2.36	2.01	0.97	Vertex Pharmaceuticals EPS beats by $0.31, beats on revenue [10/29/2020 4:09 PM]	208.18	1.17 (0.57%)	205.90	-1.11 (-0.54%)	194.20 - 306.08	2,424,654	2,854,027	20,203

30-07-2020	AH	4:00 PM ET (Jul 30)	VRTX	Vertex Pharmaceuticals Incorporated	72,210	2.26	1.75	0.99	Vertex Pharmaceuticals EPS beats by $0.53, beats on revenue [7/30/2020 4:16 PM]	270.15	-9.25 (-3.31%)	284.85	5.45 (1.95%)	165.23 - 306.08	1,434,377	1,305,123	2,694